Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sarina A Piha-Paul

Showing results (1-10 of 162) with videos related to

Pageof 17
Sort By:
The Journal of Clinical and Aesthetic Dermatology|October 11, 2012
The "shield sign" in two men with metastatic salivary duct carcinoma to the skin: cutaneous metastases presenting as carcinoma hemorrhagiectoidesPhilip R Cohen, Victor G Prieto, Sarina A Piha-Paul, et al.
Cancer Drug Resistance (Alhambra, Calif.)|October 16, 2020
Quantitative analysis of taxane drug target engagement of microtubules in circulating tumor cells from metastatic castration resistant prostate cancer patients treated with CRXL301, a nanoparticle of docetaxelEiman Mukhtar, Daniel Worroll, Giuseppe Galletti, et al.
Journal of Immunotherapy and Precision Oncology|March 12, 2025
Advancing Understanding and Therapeutic Strategies for NUT Sarcomas: Comprehensive Review of the Literature and Two CasesCarlos Torrado, Elise Nassif Haddad, Neeta Somaiah, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 9, 2017
Safety and Antitumor Activity of the Anti-Programmed Death-1 Antibody Pembrolizumab in Patients With Advanced Esophageal CarcinomaToshihiko Doi, Sarina A Piha-Paul, Shadia I Jalal, et al.
Cutis|June 25, 2019
Vandetanib photoinduced cutaneous toxicitiesHung Q Doan, Mimi I Hu, Jennifer Goldstein, et al.
Oncotarget|April 16, 2020
A mutation-specific, single-arm, phase 2 study of dovitinib in patients with advanced malignanciesMatthew H Taylor, Ajjai S Alva, Timothy Larson, et al.
Anticancer Research|April 3, 2014
Pediatric patients with refractory central nervous system tumors: experiences of a clinical trial combining bevacizumab and temsirolimusSarina A Piha-Paul, Sang Joon Shin, Tribhawan Vats, et al.
The Oncologist|September 24, 2025
Less frequent intravenous dosing of nemvaleukin alfa in patients with advanced solid tumors: the phase 1/2 ARTISTRY-3 trialSarina A Piha-Paul, Justin A Call, Alexander I Spira, et al.
Scientific Reports|February 12, 2021
Pembrolizumab in vaginal and vulvar squamous cell carcinoma: a case series from a phase II basket trialJeffrey A How, Amir A Jazaeri, Pamela T Soliman, et al.
Clinical Pharmacokinetics|March 9, 2021
The Effect of Renal Impairment on the Pharmacokinetics and Safety of Talazoparib in Patients with Advanced Solid TumorsChandrasekar Durairaj, Jayeta Chakrabarti, Cristiano Ferrario, et al.
Pageof 17

Showing results (1-10 of 162) with videos related to

Sort By:
Pageof 17
The Journal of Clinical and Aesthetic Dermatology|October 11, 2012
The "shield sign" in two men with metastatic salivary duct carcinoma to the skin: cutaneous metastases presenting as carcinoma hemorrhagiectoidesPhilip R Cohen, Victor G Prieto, Sarina A Piha-Paul, et al.
Cancer Drug Resistance (Alhambra, Calif.)|October 16, 2020
Quantitative analysis of taxane drug target engagement of microtubules in circulating tumor cells from metastatic castration resistant prostate cancer patients treated with CRXL301, a nanoparticle of docetaxelEiman Mukhtar, Daniel Worroll, Giuseppe Galletti, et al.
Journal of Immunotherapy and Precision Oncology|March 12, 2025
Advancing Understanding and Therapeutic Strategies for NUT Sarcomas: Comprehensive Review of the Literature and Two CasesCarlos Torrado, Elise Nassif Haddad, Neeta Somaiah, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 9, 2017
Safety and Antitumor Activity of the Anti-Programmed Death-1 Antibody Pembrolizumab in Patients With Advanced Esophageal CarcinomaToshihiko Doi, Sarina A Piha-Paul, Shadia I Jalal, et al.
Cutis|June 25, 2019
Vandetanib photoinduced cutaneous toxicitiesHung Q Doan, Mimi I Hu, Jennifer Goldstein, et al.
Oncotarget|April 16, 2020
A mutation-specific, single-arm, phase 2 study of dovitinib in patients with advanced malignanciesMatthew H Taylor, Ajjai S Alva, Timothy Larson, et al.
Anticancer Research|April 3, 2014
Pediatric patients with refractory central nervous system tumors: experiences of a clinical trial combining bevacizumab and temsirolimusSarina A Piha-Paul, Sang Joon Shin, Tribhawan Vats, et al.
The Oncologist|September 24, 2025
Less frequent intravenous dosing of nemvaleukin alfa in patients with advanced solid tumors: the phase 1/2 ARTISTRY-3 trialSarina A Piha-Paul, Justin A Call, Alexander I Spira, et al.
Scientific Reports|February 12, 2021
Pembrolizumab in vaginal and vulvar squamous cell carcinoma: a case series from a phase II basket trialJeffrey A How, Amir A Jazaeri, Pamela T Soliman, et al.
Clinical Pharmacokinetics|March 9, 2021
The Effect of Renal Impairment on the Pharmacokinetics and Safety of Talazoparib in Patients with Advanced Solid TumorsChandrasekar Durairaj, Jayeta Chakrabarti, Cristiano Ferrario, et al.
Pageof 17